(1 - 31 from 31
)
David Urdal - akampion
www.akampion.com
In Forbes, Matthew Herper features an interview with David Urdal, the now retiring CSO of Dendreon, who pioneered Provenge, the prostate cancer vaccine ...
Dendreon Corporation (NASDAQ:DNDN) - Dendreon Corp. Vice ...
www.benzinga.com
In a Form 4 filed after the bell today, Dendreon Corp. (NASDAQ: DNDN) Vice- President, David Urdal, reported that he sold shares of ...
Dendreon Corp. (DNDN) CFO, SVP - GuruFocus.com
www.gurufocus.com
Sell: SVP, Chief Scientific Officer David Urdal sold 4,000 shares of DNDN stock on at the average price of David Urdal owns ...
sorted by relevance / date